Our finding that an EPAC1 pharmacological inhibitor prevents viral infection suggests that virus infection is probably linked to an increase in the intracellular production of cAMP since EPAC1 activity is activated by this cyclic nucleotide. The gene discussed is RAPGEF3; the disease is viral infectious disease.